The use of enoxaparin as bridge to therapeutic INR after LVAD implantation

BACKGROUND: Left ventricular assist devices (LVAD) have been increasingly used in the treatment of end-stage heart failure. While warfarin has been uniformly recommended in the long-term as anticoagulation strategy, no clear recommendation exists for the post-operative period. We sought to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Zubair, Mastoris, Ioannis, Acharya, Prakash, Rali, Aniket S., Mohammed, Moghni, Farhad, Sami, Ranka, Sagar, Wagner, Savahanna, Zanotti, Giorgio, Salerno, Christopher T., Haglund, Nicholas A., Sauer, Andrew J., Ravichandran, Ashwin K., Abicht, Travis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666514/
https://www.ncbi.nlm.nih.gov/pubmed/33189134
http://dx.doi.org/10.1186/s13019-020-01373-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666514/
https://www.ncbi.nlm.nih.gov/pubmed/33189134
http://dx.doi.org/10.1186/s13019-020-01373-y

Ejemplares similares